Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...

New classes of drugs like the SGLT-2 Inhibitors and GLP-1 Receptor Agonists  have tremendous potential for managing the blood ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

and non-insulin treated, then evaluated their use of CGM both before and after initiating GLP-1 medications. Citation: Jimmy Zheng, et al. Contemporary Decongestion Strategies in Patients Hospitalized ...

NRBO READ THE FULL NRBO RESEARCH REPORT Business Update   Topline Results from Phase 2a Trial of DA-1241 in MASH Expected in ...